Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1869 1
1945 1
1948 5
1949 2
1950 1
1951 3
1953 2
1959 1
1960 2
1961 3
1962 4
1963 3
1964 3
1965 5
1966 4
1967 4
1969 3
1970 3
1971 1
1972 5
1973 3
1974 9
1975 7
1976 11
1977 7
1978 11
1979 12
1980 7
1981 8
1982 9
1983 7
1984 14
1985 9
1986 9
1987 16
1988 22
1989 13
1990 20
1991 20
1992 17
1993 14
1994 9
1995 12
1996 18
1997 17
1998 13
1999 13
2000 9
2001 18
2002 16
2003 17
2004 20
2005 23
2006 22
2007 17
2008 30
2009 30
2010 34
2011 36
2012 43
2013 46
2014 59
2015 49
2016 54
2017 59
2018 70
2019 56
2020 66
2021 75
2022 46
2023 44
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

1,238 results

Results by year

Filters applied: . Clear all
Page 1
Metformin, Macrophage Dysfunction and Atherosclerosis.
Feng X, Chen W, Ni X, Little PJ, Xu S, Tang L, Weng J. Feng X, et al. Among authors: little pj. Front Immunol. 2021 Jun 7;12:682853. doi: 10.3389/fimmu.2021.682853. eCollection 2021. Front Immunol. 2021. PMID: 34163481 Free PMC article. Review.
Mouse models of atherosclerosis in translational research.
Ilyas I, Little PJ, Liu Z, Xu Y, Kamato D, Berk BC, Weng J, Xu S. Ilyas I, et al. Among authors: little pj. Trends Pharmacol Sci. 2022 Nov;43(11):920-939. doi: 10.1016/j.tips.2022.06.009. Epub 2022 Jul 25. Trends Pharmacol Sci. 2022. PMID: 35902281 Review.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Butler CC, Hobbs FDR, Gbinigie OA, Rahman NM, Hayward G, Richards DB, Dorward J, Lowe DM, Standing JF, Breuer J, Khoo S, Petrou S, Hood K, Nguyen-Van-Tam JS, Patel MG, Saville BR, Marion J, Ogburn E, Allen J, Rutter H, Francis N, Thomas NPB, Evans P, Dobson M, Madden TA, Holmes J, Harris V, Png ME, Lown M, van Hecke O, Detry MA, Saunders CT, Fitzgerald M, Berry NS, Mwandigha L, Galal U, Mort S, Jani BD, Hart ND, Ahmed H, Butler D, McKenna M, Chalk J, Lavallee L, Hadley E, Cureton L, Benysek M, Andersson M, Coates M, Barrett S, Bateman C, Davies JC, Raymundo-Wood I, Ustianowski A, Carson-Stevens A, Yu LM, Little P; PANORAMIC Trial Collaborative Group. Butler CC, et al. Among authors: little p. Lancet. 2023 Jan 28;401(10373):281-293. doi: 10.1016/S0140-6736(22)02597-1. Epub 2022 Dec 22. Lancet. 2023. PMID: 36566761 Free PMC article. Clinical Trial.
FOXO Signaling Pathways as Therapeutic Targets in Cancer.
Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W. Farhan M, et al. Among authors: little pj. Int J Biol Sci. 2017 Jul 6;13(7):815-827. doi: 10.7150/ijbs.20052. eCollection 2017. Int J Biol Sci. 2017. PMID: 28808415 Free PMC article. Review.
1,238 results